Telix Pharmaceuticals Limited (TLX) Capital expenditures 2023–2025
Telix Pharmaceuticals Limited (TLX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$25.7MFY2025 · since FY2023: $6.3M → $25.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $25.7M | +181.8% |
| FY2024 | $9.1M | +44.6% |
| FY2023 | $6.3M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice